The companies aim to co-develop TCR-TCE constructs, which will be owned equally by both partners. “We are delighted to partner with EpimAb and their proprietary T-FIT platform, which is well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback